Robert M. Di Scipio, President, CEO and Chairman of the Board , has more than 22 years of leadership experience in business development, sales management, corporate law, and debt and equity finance, including executive positions with biotechnology, software and technology companies. Mr. Di Scipio is the founder of Skyland Capital, a late stage venture capital firm. His biotechnology career includes Martek Biosciences (NASDAQ:MATK), where he served as Vice President, Business Development and Associate General Counsel and was a member of the Executive Committee. Prior to Martek, Mr. Di Scipio was Vice President, Corporate Development and General Counsel and Secretary for OmegaTech, where as a member of the Executive Committee, he managed legal affairs, Asia/Pacific sales, the Gold Circle Farms consumer brand, intellectual property strategy and licensing, debt and equity financings and negotiated the company’s merger with Martek. Earlier in his career, Mr. Di Scipio was managing partner of the Connecticut law firm Hawthorne, Ackerly & Dorrance and an attorney with Coopers & Lybrand. He currently sits on the Board of Directors of Barofold, which licenses its drug development technology to leading pharmaceutical and biotechnology companies, and ePals, a provider of email and Internet-filtering technology to the education market . Mr. Di Scipio received his B.A. from the University of Michigan and a J.D. from Pace University. He is a member of the bars of New York and Connecticut.